Trial Profile
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Apadenoson (Primary) ; Adenosine
- Indications Coronary artery disease
- Focus Diagnostic use
- Acronyms ASPECT
- Sponsors Forest Laboratories
- 04 Jun 2014 New trial record